Subsequent Events	12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	(22) Subsequent Events At the Market Offerings During the period of January 1, 2025 through March 14, 2025, we received net proceeds of approximately $4.4 million under the Sales Agreement. Subordinated Note Amendment On February 20, 2025, we entered into an Amendment to Notes, Amendment of Warrants and Sale of New Warrants (the “Amendment”) with existing noteholders, pursuant to which we: • extended the maturity date of $10.5 million of the 2015 Subordinated Notes by sixteen months from February 20, 2025 to July 20, 2026; • increased the interest rate under the 2015 Subordinated Notes from 8% to 9% per annum; • extended the expiration date of all A Warrants and B Warrants held by such noteholders to purchase a total of 97,500 shares of the Company’s common stock previously issued in 2022 to February 20, 2030 and changed the exercise price to $3.25 per share, which represented a 60-day volume weighted average price as of February 14, 2025 (the “Amended A Warrants” and “Amended B Warrants”); • issued to certain noteholders new warrants to purchase 67,500 shares of the Company’s common stock to expire February 30, 2030, and have an exercise price of $3.25 per share, (the “C Warrants” and, together with the Amended A Warrants and the Amended B Warrants, the “New Warrants”); and • provided that if we conduct a financing of greater than $10.0 million at a price per share below $3.25 before February 20, 2026, the exercise price on the New Warrants will be reduced to the same price at which such financing was conducted.

Subsequent Events

12 Months Ended

Dec. 31, 2024

(22) Subsequent Events

At the Market Offerings

During the period of January 1, 2025 through March 14, 2025, we received net proceeds of approximately $4.4 million under the Sales Agreement.

Subordinated Note Amendment

On February 20, 2025, we entered into an Amendment to Notes, Amendment of Warrants and Sale of New Warrants (the “Amendment”) with existing noteholders, pursuant to which we:

•

extended the maturity date of $10.5 million of the 2015 Subordinated Notes by sixteen months from February 20, 2025 to July 20, 2026;

•

increased the interest rate under the 2015 Subordinated Notes from 8% to 9% per annum;

•

extended the expiration date of all A Warrants and B Warrants held by such noteholders to purchase a total of 97,500 shares of the Company’s common stock previously issued in 2022 to February 20, 2030 and changed the exercise price to $3.25 per share, which represented a 60-day volume weighted average price as of February 14, 2025 (the “Amended A Warrants” and “Amended B Warrants”);

•

issued to certain noteholders new warrants to purchase 67,500 shares of the Company’s common stock to expire February 30, 2030, and have an exercise price of $3.25 per share, (the “C Warrants” and, together with the Amended A Warrants and the Amended B Warrants, the “New Warrants”); and

•

provided that if we conduct a financing of greater than $10.0 million at a price per share below $3.25 before February 20, 2026, the exercise price on the New Warrants will be reduced to the same price at which such financing was conducted.